A randomized, single blind, repeat dose, placebo-controlled, single-period, parallel group study to investigate the safety, tolerability and potential pharmacokinetic interactions between GW856553 and rosuvastatin (10mg), when co-administered in healthy adult male subjects

Trial Profile

A randomized, single blind, repeat dose, placebo-controlled, single-period, parallel group study to investigate the safety, tolerability and potential pharmacokinetic interactions between GW856553 and rosuvastatin (10mg), when co-administered in healthy adult male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Losmapimod; Rosuvastatin
  • Indications Acute coronary syndromes; Atherosclerosis; Cardiovascular disorders; Chronic obstructive pulmonary disease; Depressive disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 May 2009 Exclusion criteria amended from NCT
    • 21 Apr 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top